[Translation] A randomized, parallel-group, 24-week, double-blind, placebo-controlled, multicenter, phase III study evaluating the efficacy and safety of secukinumab compared with placebo in adult subjects with rotator cuff tendinopathy .
本研究的目的是评估司库奇尤单抗300 mg s.c.(皮下)+ 标准治疗相比安慰剂 + 标准治疗在改善中度至重度肩袖肌腱病(RCT)受试者的体征、症状和身体功能方面的疗效
[Translation] The aim of this study was to evaluate the improvement of signs, symptoms and physical function of subjects with moderate to severe rotator cuff tendinopathy (RCT) with secukinumab 300 mg s.c. (subcutaneous) + standard care compared with placebo + standard care curative effect